Fri, October 28, 2011
[ Fri, Oct 28th 2011 ] - Market Wire
Almost Family, Inc. to Report Third Quarter 2011 Financial Results on November 2, 2011
[ Fri, Oct 28th 2011 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation of K-V Pharmaceutical Company
[ Fri, Oct 28th 2011 ] - Market Wire
Poniard Pharmaceuticals Reports Third Quarter 2011 Financial Results
[ Fri, Oct 28th 2011 ] - Market Wire
Ergoresearch Ltd Reports Growing Sales of 9.0% fo .. 30, 2011. Earnings Before Tax for the Period Amou
[ Fri, Oct 28th 2011 ] - Market Wire
ZIOPHARM Presents Promising Preclinical Pediatric .. nd IV Palifosfamide at the 2011 CTOS/MSTS Meeting
[ Fri, Oct 28th 2011 ] - Market Wire
Medtronic Receives IDE Approval to Conduct ASPIRE .. sulin Pump with Low Glucose Suspend for US Market
[ Fri, Oct 28th 2011 ] - Market Wire
MannKind Corporation to Hold 2011 Third Quarter F .. ncial Results Conference Call on November 3, 2011
[ Fri, Oct 28th 2011 ] - Market Wire
Advaxis Receives Additional Financing
[ Fri, Oct 28th 2011 ] - Market Wire
The Medicines Company and Daiichi Sankyo Announce Angiox(R) (Bivalirudin) Co-Promotion for Germany
[ Fri, Oct 28th 2011 ] - Market Wire
What's Ahead: Today's Economic Outlook - Equity R .. Mylan Inc. and Medicis Pharmaceutical Corporation
[ Fri, Oct 28th 2011 ] - Market Wire
Egan-Jones Recommends Poniard Shareholders Vote " .. osed Merger With ALLOZYNE and Reverse Stock Split
[ Fri, Oct 28th 2011 ] - Market Wire
Analyst Research on Sequenom Inc. and Life Techno .. Companies Succeeding in Bringing Products to the
[ Fri, Oct 28th 2011 ] - Market Wire
Pfizer Completes Acquisition Of Icagen
[ Fri, Oct 28th 2011 ] - Market Wire
Gilead deposita una domanda di approvazione di nu .. per gli Alimenti e i Medicinali statunitense (Foo
[ Fri, Oct 28th 2011 ] - Market Wire
Salix Pharmaceuticals Previews American College of Gastroenterology 2011
[ Fri, Oct 28th 2011 ] - Market Wire
Gilead stellt Zulassungsantrag bei der FDA fr neu .. r HIV-Therapie mit tglich einer einzigen Tablette
[ Fri, Oct 28th 2011 ] - Market Wire
Threshold Pharmaceuticals Reports Further Promising Data With TH-302 in Soft Tissue Sarcoma
Thu, October 27, 2011
[ Thu, Oct 27th 2011 ] - Market Wire
Unity Powers Army OneSource Virtual World
[ Thu, Oct 27th 2011 ] - Market Wire
Biogen Idec en Portola Pharmaceuticals kondigen i .. n voor oraal syk-remmerprogramma gericht op auto-
[ Thu, Oct 27th 2011 ] - Market Wire
Pfizer Declares A 20-Cent Fourth-Quarter 2011 Dividend
[ Thu, Oct 27th 2011 ] - Market Wire
Crystal Research Associates, LLC Issues Executive .. al Overview (EIO) on Adamis Pharmaceuticals Corp.
[ Thu, Oct 27th 2011 ] - Market Wire
FMX Ventures Inc. and Tolima Gold Corp. Announce .. or and Commencement of Private Placement Offering
[ Thu, Oct 27th 2011 ] - Market Wire
Cannabis Science Releases First Cannabis-Extract- .. Now at Cannabis Therapeutics, 957 E. Fillmore St,
[ Thu, Oct 27th 2011 ] - Market Wire
Biogen Idec e Portola Pharmaceuticals hanno annun .. ale per Oral Syk, il programma inibitore specific
[ Thu, Oct 27th 2011 ] - Market Wire
Biogen Idec et Portola Pharmaceuticals annoncent .. ns le cadre daun programme dainhibiteur oral de l
[ Thu, Oct 27th 2011 ] - Market Wire
Biogen Idec und Portola Pharmaceuticals verknden .. rogramm fr den oral verabreichten SYK-Inhibitor b
[ Thu, Oct 27th 2011 ] - Market Wire
Health Net Federal Services Launches Mobile Site .. he-Go Access to Health Care for Military Families
[ Thu, Oct 27th 2011 ] - Market Wire
Human Genome Sciences and Xoma Fall Victim to Volatile Nature of Biotech Sector
[ Thu, Oct 27th 2011 ] - Market Wire
PharmaGap Sets Time for in Vivo Tests
[ Thu, Oct 27th 2011 ] - Market Wire
Dynavax Phase 3 Data in Chronic Kidney Disease De .. rates Superiority of HEPLISAV(TM) vs Engerix-B(R)
[ Thu, Oct 27th 2011 ] - Market Wire
Implant Sciences Explosives Detection Technology Protects Major European Bank
[ Thu, Oct 27th 2011 ] - Market Wire
Acorda Therapeutics to Host Conference Call to Di .. uarter 2011 Financial Results on November 4, 2011
[ Thu, Oct 27th 2011 ] - Market Wire
ICON Reports Q3 revenue growth of 7% to $241 mill .. f $431 million. (NASDAQ:ICLR) (ISIN:IE0005711209)
[ Thu, Oct 27th 2011 ] - Market Wire
Pfizer Receives European Approval to Extend Use o .. ars and Older for the Prevention of Invasive Pneu
Wed, October 26, 2011
[ Wed, Oct 26th 2011 ] - Market Wire
Universal American Corp. Reports Third Quarter 2011 Results
[ Wed, Oct 26th 2011 ] - Market Wire
Medtronic Starts Landmark Study of Hypertension Treatment
[ Wed, Oct 26th 2011 ] - Market Wire
Biogen Idec oglasza pozytywne podsumowanie wynikw .. 3. badan nad doustnym BG-12 u pacjentw ze stward
[ Wed, Oct 26th 2011 ] - Market Wire
Stellar Biotechnologies &;; Life Diagno .. e Agreement for Stellar Brand KLH ELISA Test Kits
[ Wed, Oct 26th 2011 ] - Market Wire
2011 Third Quarter and Nine-Month Results
[ Wed, Oct 26th 2011 ] - Market Wire
Seattle Genetics Appoints Vice President, Medical .. nces Vice President, Quality Management Promotion
[ Wed, Oct 26th 2011 ] - Market Wire
Abiomed to Release New Protect II Data and Econom .. #59; Over 20 Impella Presentations Included i
[ Wed, Oct 26th 2011 ] - Market Wire
Health Canada Clears Immunovaccine for Ovarian Cancer Vaccine Trials
[ Wed, Oct 26th 2011 ] - Market Wire
Cytori to Webcast Third Quarter Financial Results November 3
[ Wed, Oct 26th 2011 ] - Market Wire
Magellan Health Services Joins with Share Our Strength to End Childhood Hunger in America
[ Wed, Oct 26th 2011 ] - Market Wire
Octapharma Locks-in Binding Forecast to Exceed $2M for ProMetic's Prion Capture Resin for H1 2012
[ Wed, Oct 26th 2011 ] - Market Wire
Amedisys Announces Third Quarter Earnings Release and Conference Call Date
[ Wed, Oct 26th 2011 ] - Market Wire
Covidien Launches Worldas First Non-Absorbable, Uni-Directional Knotless Suture
[ Wed, Oct 26th 2011 ] - Market Wire
Biogen Idec annonce des rsultats trs positifs l'i .. se 3 tudiant BG-12 (dimthylfumarate) administr pa
[ Wed, Oct 26th 2011 ] - Market Wire
Biogen Idec annuncia risultati preliminari positi .. ico di fase III del farmaco orale BG-12 (dimetilf
[ Wed, Oct 26th 2011 ] - Market Wire
Biogen Idec Announces Positive Top-Line Results f .. stigating Oral BG-12 (Dimethyl Fumarate) in Multi
[ Wed, Oct 26th 2011 ] - Market Wire
Biogen Idec meldet positive Topline-Ergebnisse au .. zur Prfung von oral verabreichtem BG-12 (Dimethyl
Tue, October 25, 2011
[ Tue, Oct 25th 2011 ] - Market Wire
West to Host 2011 Third Quarter Conference Call
[ Tue, Oct 25th 2011 ] - Market Wire
CytoSorbents Corporation to Present at the IN3 Medical Device Summit
[ Tue, Oct 25th 2011 ] - Market Wire
USANA Health Sciences Reports Third Quarter 2011 Financial Results
[ Tue, Oct 25th 2011 ] - Market Wire
Micro Imaging Technology Receives a Substantial Exclusive Licensing Proposal From EPIC Corporation
[ Tue, Oct 25th 2011 ] - Market Wire
Daniel Levangie Appointed to Insulet's Board of Directors
[ Tue, Oct 25th 2011 ] - Market Wire
The Law Firm of Levi &;; Korsinsky Noti .. Their Investment in K-V Pharmaceutical Company o
[ Tue, Oct 25th 2011 ] - Market Wire
VistaGen Therapeutics Reports Identification of C .. ts High-Yield Purification of Human Pluripotent S
[ Tue, Oct 25th 2011 ] - Market Wire
Amarantus BioSciences Appoints Dr. Owen Garrick as Strategic Advisor
[ Tue, Oct 25th 2011 ] - Market Wire
What's Ahead: Today's Economic Outlook - Equity R .. earch on Thoratec Corporation and C.R. Bard, Inc.
[ Tue, Oct 25th 2011 ] - Market Wire
Daxor Announces Filing of Patents for Total Body Albumin Analyzer
[ Tue, Oct 25th 2011 ] - Market Wire
OmniGuide Appoints Scott Flora as President & CEO
[ Tue, Oct 25th 2011 ] - Market Wire
ZYTO Corp Appoints Leading Experts to Scientific Advisory Board
[ Tue, Oct 25th 2011 ] - Market Wire
Implant Sciences Sells Follow-On Order to China's Beijing Subway System
[ Tue, Oct 25th 2011 ] - Market Wire
Gilead e GlobeImmune annunciano un contratto di l .. o sviluppo di vaccini terapeutici per il trattame
[ Tue, Oct 25th 2011 ] - Market Wire
Dr. Reddyas Q2 FY12 Financial Results
[ Tue, Oct 25th 2011 ] - Market Wire
Exelixis Appoints Executive Vice President and Chief Commercial Officer
[ Tue, Oct 25th 2011 ] - Market Wire
DaVita Announces Government Inquiry
Mon, October 24, 2011
[ Mon, Oct 24th 2011 ] - Market Wire
Merck Announces Presentation of Phase III Investi .. ULERA (mometasone furoate and formoterol fumarate
[ Mon, Oct 24th 2011 ] - Market Wire
Blinded Results From Low Dose Cohort of Phase II SHIGATEC Trial Presented at IDSA Annual Meeting
[ Mon, Oct 24th 2011 ] - Market Wire
The Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of Adolor Corporation
[ Mon, Oct 24th 2011 ] - Market Wire
Harwood Feffer LLP Announces Investigation of HealthSpring Inc.
[ Mon, Oct 24th 2011 ] - Market Wire
Edison Expands Cell Therapy Sector Presence with Launch of Research Coverage on Aastrom
[ Mon, Oct 24th 2011 ] - Market Wire
Diligent Boardbooks Announces Fifth Consecutive R .. r, Boardbooks Now Used by 62 TSX Listed Companies
[ Mon, Oct 24th 2011 ] - Market Wire
Syneron Medical to Report Third Quarter 2011 Financial Results on November 10, 2011
[ Mon, Oct 24th 2011 ] - Market Wire
What's Ahead: Today's Economic Outlook - Equity R .. Ware International Inc and St. Jude Medical, Inc.
[ Mon, Oct 24th 2011 ] - Market Wire
Growing Safety Concerns Weigh on Medical Equipment and Supplies Sector
[ Mon, Oct 24th 2011 ] - Market Wire
NPS Pharmaceuticals Reports Upcoming Presentation .. ege of Gastroenterology Annual Scientific Meeting
[ Mon, Oct 24th 2011 ] - Market Wire
Cigna to Acquire HealthSpring
[ Mon, Oct 24th 2011 ] - Market Wire
PharmaGap Chooses Ovarian Cancer as Target for First Clinical Trials
[ Mon, Oct 24th 2011 ] - Market Wire
Research on GlaxoSmithKline plc and Merck &;; Co. Inc. -- Big Pharma Stable for Now
[ Mon, Oct 24th 2011 ] - Market Wire
SecureAlert, Inc. Achieves Milestone of Deploymen .. Units of Its Newest ReliAlert(TM) GPS Tracking a
[ Mon, Oct 24th 2011 ] - Market Wire
Aeolus Pharmaceuticals Announces NIH Counteract G .. 10150 as a Treatment Against Nerve Agent Exposure
[ Mon, Oct 24th 2011 ] - Market Wire
Novadaq to Release Q3-2011 Financial Results on November 4-Conference Call to Follow
[ Mon, Oct 24th 2011 ] - Market Wire
Waters Recognizes the Dr. Ganesh Anand Laboratory .. l University of Singapore as Center of Innovation
Sat, October 22, 2011
[ Sat, Oct 22nd 2011 ] - Market Wire
Biogen Idec und Abbott prsentieren positive Daten .. ase-IIb-Studie SELECT auf dem ECTRIMS/ACTRIMS-Kon
[ Sat, Oct 22nd 2011 ] - Market Wire
Zimmer presenta il sistema a vite pedicolare Path .. minimamente invasivo destinato al mercato europeo
[ Sat, Oct 22nd 2011 ] - Market Wire
Biogen Idec en Abbott presenteren positieve resul .. P uit Select fase 2b onderzoek op ECTRIMS/ACTRIMS
[ Sat, Oct 22nd 2011 ] - Market Wire
Biogen Idec et Abbott pr©sentent les r©sultats .. phase 2b pour le Daclizumab HYP lors du congrs EC
Fri, October 21, 2011
[ Fri, Oct 21st 2011 ] - Market Wire
Kahn Swick &;; Foti, LLC and Former Lou .. nce Securities Class Action Lawsuit Against K-V P
[ Fri, Oct 21st 2011 ] - Market Wire
Data From Phase 2 Clinical Studies of Telotristat .. rcinoid Syndrome to be Presented at North America
[ Fri, Oct 21st 2011 ] - Market Wire
Valeant Pharmaceuticals to Announce 2011 Third Quarter Results on November 3, 2011
[ Fri, Oct 21st 2011 ] - Market Wire
Federman &;; Sherwood Announces That a .. it Has Been Filed Against K-V Pharmaceutical Comp
[ Fri, Oct 21st 2011 ] - Market Wire
AMAG Pharmaceuticals Announces Results of Special Stockholder Meeting Regarding Proposed Merger
[ Fri, Oct 21st 2011 ] - Market Wire
Dynavax and GlaxoSmithKline Expand Their Worldwide Strategic Alliance
[ Fri, Oct 21st 2011 ] - Market Wire
Wall Street Reporter, Inc. Interviews Micro Imagi .. echnology, Inc. Chairman and CEO, Michael Brennan
[ Fri, Oct 21st 2011 ] - Market Wire
AVI BioPharma's RNA-Based Therapeutics for Treatm .. ses Show Positive Safety Data in First Five of Si
[ Fri, Oct 21st 2011 ] - Market Wire
For The Earth Corporation Strengthens Its Portfolio With Kat Box King
[ Fri, Oct 21st 2011 ] - Market Wire
GTx, Inc. To Host Third Quarter 2011 Financial Results Conference Call and Webcast
[ Fri, Oct 21st 2011 ] - Market Wire
Teleflex Signs Definitive Agreement to Sell Aerospace Businesses for $280 Million
[ Fri, Oct 21st 2011 ] - Market Wire
Magellan Health Services to Present at Academy of Managed Care Pharmacy Educational Conference
[ Fri, Oct 21st 2011 ] - Market Wire
Oral BG-12 (Dimetil Fumarato) reduce notablemente .. con esclerosis multiple (MS) y el avance de la d
[ Fri, Oct 21st 2011 ] - Market Wire
Oraal toegediende BG-12 (dimethyl fumaraat) reduc .. lerose en voortschrijding aftakeling in Fase 3 DE
[ Fri, Oct 21st 2011 ] - Market Wire
Acorda Therapeutics Announces Data on AMPYRA® Pr .. h Joint Triennial Congress of ECTRIMS and ACTRIMS
[ Fri, Oct 21st 2011 ] - Market Wire
Reduzierte Schubhufigkeit und Behinderungsprogres .. durch oral verabreichtes BG-12 (Dimethylfumarat):
[ Fri, Oct 21st 2011 ] - Market Wire
Selon les observations de l'essai clinique DEFINE .. -12 (dim©thylfumarate) r©duit de manire signifi
Thu, October 20, 2011
[ Thu, Oct 20th 2011 ] - Market Wire
Biogen Idec und Elan melden Verlngerung der PDUFA-Frist
[ Thu, Oct 20th 2011 ] - Market Wire
Biogen Idec y Elan reciben notificacin de ampliacin de la fecha PDUFA
[ Thu, Oct 20th 2011 ] - Market Wire
Critical Outcome Technologies Inc. Successfully Completes Critical Study
[ Thu, Oct 20th 2011 ] - Market Wire
Analyst View, Impact of Global Events - Research .. on &;; Johnson and Endo Pharmaceuticals
[ Thu, Oct 20th 2011 ] - Market Wire
Dendreon Announces Webcast Presentations at Upcoming Conferences
[ Thu, Oct 20th 2011 ] - Market Wire
Biogen Idec and Elan Receive Notification of PDUFA Date Extension
[ Thu, Oct 20th 2011 ] - Market Wire
Alnylam to Webcast Presentation at the Newsmakers in the Biotech Industry 2011 Conference
[ Thu, Oct 20th 2011 ] - Market Wire
Allon Therapeutics Announces Completion of Patient Enrollment in Pivotal Trial
[ Thu, Oct 20th 2011 ] - Market Wire
POZEN Announces November 3, 2011 Webcast of Third Quarter 2011 Results
[ Thu, Oct 20th 2011 ] - Market Wire
Geron Presents Clinical Data Update From GRNOPC1 Spinal Cord Injury Trial
[ Thu, Oct 20th 2011 ] - Market Wire
Cambridge Heart Announces Initial Results of OEM Module Marketing Promotion
[ Thu, Oct 20th 2011 ] - Market Wire
Manchester Heart Centre in United Kingdom Obtains VMS(TM) Heart Analysis System
[ Thu, Oct 20th 2011 ] - Market Wire
Covidien Releases Clinical Data from Largest Pros .. Plaque Excision for Treatment of Peripheral Arter
[ Thu, Oct 20th 2011 ] - Market Wire
Five Star Quality Care, Inc. Third Quarter Conference Call Scheduled for Thursday, October 27th
[ Thu, Oct 20th 2011 ] - Market Wire
Syneron kndigt weltweite Einfhrung einer neuen Ko .. echnologien fr die Gesichtsbehandlung mit dem eTw
[ Thu, Oct 20th 2011 ] - Market Wire
Device Master File for OncoSec Medical System Completed and Submitted to FDA
[ Thu, Oct 20th 2011 ] - Market Wire
Comprehensive Care Corporation CEO Clark A. Marcus Praised for U.S. Chamber of Commerce Service
Wed, October 19, 2011
[ Wed, Oct 19th 2011 ] - Market Wire
Sun Healthcare Group, Inc. to Release Third-Quarter Results for 2011 and Schedules Conference Call
[ Wed, Oct 19th 2011 ] - Market Wire
CML HealthCare Inc. Declares October Dividend
[ Wed, Oct 19th 2011 ] - Market Wire
Gegevens over vroeg gebruik en baten op lange ter .. d op 5de gezamenlijk driejaarlijks congres over b
[ Wed, Oct 19th 2011 ] - Market Wire
Des r©sultats relatifs l'utilisation pr©coce et .. YSABRI sont pr©sent©s l'occasion du 5e Congrs t
[ Wed, Oct 19th 2011 ] - Market Wire
Los datos sobre el uso temprano y los beneficios .. sido presentados en el 5 congreso trienal conjun
[ Wed, Oct 19th 2011 ] - Market Wire
Theratechnologies Announces Application for Registration of Tesamorelin in Mexico
[ Wed, Oct 19th 2011 ] - Market Wire
Diligent Board Member Services Ranked Number 156 .. rth America on Deloitte's 2011 Technology Fast 50
[ Wed, Oct 19th 2011 ] - Market Wire
Marina Biotech Demonstrates In Vivo Dose-Dependen .. erability With a CRN-Substituted miRNA Antagonist
[ Wed, Oct 19th 2011 ] - Market Wire
Ardea Biosciences to Present Data From Gout Program at the 2011 ACR/ARHP Annual Scientific Meeting
[ Wed, Oct 19th 2011 ] - Market Wire
UNITEDHEALTHCARE OFRECE AUDFONOS SIN COSTO DE DES .. PARA LOS BENEFICIARIOS DEL CONDADO DE MIAMI-DADE
[ Wed, Oct 19th 2011 ] - Market Wire
Vertex Submits Application for Priority Review an .. 770, ivacaftor) in the U.S. as First Potential Me
[ Wed, Oct 19th 2011 ] - Market Wire
Ligand Enters into Platform Captisol® License Agreement with SAGE Therapeutics
[ Wed, Oct 19th 2011 ] - Market Wire
Single Pharmaceutical-Based Strategy Aims to Solve Neurological and Psychiatric Disorders
[ Wed, Oct 19th 2011 ] - Market Wire
Daten ber Vorteile frhzeitiger bzw. langfristiger .. f 5. dreijhrlichem gemeinsamem Kongress von ECTRI
[ Wed, Oct 19th 2011 ] - Market Wire
Astex Pharmaceuticals to Present at BIO Investor Forum on October 26th
[ Wed, Oct 19th 2011 ] - Market Wire
Presentati al 5o congresso triennale congiunto di .. ivi alla?uso precoce e ai vantaggi a lungo termin
Tue, October 18, 2011
[ Tue, Oct 18th 2011 ] - Market Wire
Law Office of Brodsky & Smith, LLC Announces Investigation of Anadys Pharmaceticals, Inc.
[ Tue, Oct 18th 2011 ] - Market Wire
Vanda Pharmaceuticals to Announce Third Quarter 2011 Financial Results on November 4, 2011
[ Tue, Oct 18th 2011 ] - Market Wire
Cytokinetics Announces Strategic Restructuring
[ Tue, Oct 18th 2011 ] - Market Wire
Greatbatch, Inc. to Host Third Quarter 2011 Earnings Conference Call on October 27, 2011
[ Tue, Oct 18th 2011 ] - Market Wire
Brower Piven Encourages Investors Who Have Losses .. vestment in Stereotaxis, Inc. to Inquire About th
[ Tue, Oct 18th 2011 ] - Market Wire
Exactech Schedules Third Quarter 2011 Earnings Release and Conference Call
[ Tue, Oct 18th 2011 ] - Market Wire
Allon Therapeutics Completes Equity Offering
[ Tue, Oct 18th 2011 ] - Market Wire
Flamel Technologies Announces Multi-Year Supply A .. ith GlaxoSmithKline for Coreg CRa" Microparticles
[ Tue, Oct 18th 2011 ] - Market Wire
MethylGene Receives FDA IND Approval to Begin a P .. ith MGCD290, a Novel Antifungal Product Candidate
[ Tue, Oct 18th 2011 ] - Market Wire
Human Genome Sciences to Sponsor Conference Call to Discuss Third Quarter 2011 Financial Results
[ Tue, Oct 18th 2011 ] - Market Wire
ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2011 Financial Results
[ Tue, Oct 18th 2011 ] - Market Wire
Given Imaging Announces New Study Shows Impact of .. lCam(R) SB on Management of Symptomatic IBD Cases
[ Tue, Oct 18th 2011 ] - Market Wire
Dr. Roberto Romero, NIH Principal Investigator of .. by Columbia Laboratories, Honored with John Ding
[ Tue, Oct 18th 2011 ] - Market Wire
Reflect Scientific, Inc. Introduces Cryometrix Model B-120 Blast Freezer
[ Tue, Oct 18th 2011 ] - Market Wire
Greystone Logistics Announces Preliminary Financial Results for 1st Quarter
[ Tue, Oct 18th 2011 ] - Market Wire
DaVita Announces Estimate of Third Quarter 2011 Results
Mon, October 17, 2011
[ Mon, Oct 17th 2011 ] - Market Wire
Izard Nobel LLP Announces Class Action Lawsuit Against Stereotaxis, Inc.
[ Mon, Oct 17th 2011 ] - Market Wire
Medtronic Elects Michael O. Leavitt to the Board of Directors
[ Mon, Oct 17th 2011 ] - Market Wire
Cubist Pharmaceuticals Appoints Jennifer Jackson as Senior Vice President, Regulatory Affairs
[ Mon, Oct 17th 2011 ] - Market Wire
Tripp Levy PLLC Announces Investigation of Anadys Pharmaceuticals
[ Mon, Oct 17th 2011 ] - Market Wire
Futuremed Announces Timing of Third Quarter 2011 Results &;; Conference Call
[ Mon, Oct 17th 2011 ] - Market Wire
Leisureworld Announces October Dividend
[ Mon, Oct 17th 2011 ] - Market Wire
Medtronic Announces 510(k) Clearance for the Aqua .. ined Hemostatic Sealing and Cutting Functionality
[ Mon, Oct 17th 2011 ] - Market Wire
PharmStar Outstanding Common Stock Reduced by 50%
[ Mon, Oct 17th 2011 ] - Market Wire
AdCare Health Systems to Acquire Five Skilled Nursing Facilities in Oklahoma
[ Mon, Oct 17th 2011 ] - Market Wire
Lpath Initiates Dosing of iSONEP in Second of Two Proof-of-Concept Trials
[ Mon, Oct 17th 2011 ] - Market Wire
Marina Biotech, Inc. Announces a $15 Million Purc .. ase Agreement With Lincoln Park Capital Fund, LLC
[ Mon, Oct 17th 2011 ] - Market Wire
DMRJ Amends Implant Sciences' Credit Facility
[ Mon, Oct 17th 2011 ] - Market Wire
Immunovaccine Appoints Wayne Pisano to its Board
[ Mon, Oct 17th 2011 ] - Market Wire
Cellceutix Confident as Cancer Compound Shows Activity in All Cancers Tested
[ Mon, Oct 17th 2011 ] - Market Wire
CytoSorbents Corporation Launches HemoDefend Puri .. for Blood Transfusion Applications at the AABB Co
[ Mon, Oct 17th 2011 ] - Market Wire
Acura Pharmaceuticals Provides Update on Opioid Product Licensed to Pfizer
Sun, October 16, 2011
[ Sun, Oct 16th 2011 ] - Market Wire
China Medical Technologies Announces the Approval .. Technology Enterprise Status for a Major Subsidia
Sat, October 15, 2011
[ Sat, Oct 15th 2011 ] - Market Wire
The Medicines Company's MDCO-2010 Meets Clinical .. ectives in Patients Undergoing Open-Heart Surgery
Fri, October 14, 2011
[ Fri, Oct 14th 2011 ] - Market Wire
Par Pharmaceutical Files Declaratory Judgment to .. s to Disseminate Truthful Information Regarding M
[ Fri, Oct 14th 2011 ] - Market Wire
Sangamo BioSciences Announces Presentation at the .. ual Newsmakers in the Biotech Industry Conference
[ Fri, Oct 14th 2011 ] - Market Wire
MannKind to Present at The 18th Annual Newsmakers in the BioTech Industry Conference
[ Fri, Oct 14th 2011 ] - Market Wire
Amarillo Biosciences Issues Corporate Update
[ Fri, Oct 14th 2011 ] - Market Wire
Enzo Reports Record Revenues of $102 Million for Fiscal Year 2011
[ Fri, Oct 14th 2011 ] - Market Wire
Greatbatch, Inc. Elects Anthony P. Bihl III to its Board of Directors
[ Fri, Oct 14th 2011 ] - Market Wire
New Data on Tevaa?s Copaxone® and Laquinimod to Be Highlighted at ECTRIMS/ACTRIMS
[ Fri, Oct 14th 2011 ] - Market Wire
Dynavax to Present at Newsmakers in the Biotech Industry Conference
[ Fri, Oct 14th 2011 ] - Market Wire
MSA Completes Sale of North Carolina Ballistic Vest Business
[ Fri, Oct 14th 2011 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation of Stereotaxis, Inc.
[ Fri, Oct 14th 2011 ] - Market Wire
Teva Completes Acquisition of Cephalon
[ Fri, Oct 14th 2011 ] - Market Wire
Brookwater Announces Hiring of One of the Largest .. physical &;; Geological Teams in Brazil
[ Fri, Oct 14th 2011 ] - Market Wire
Funding Security Critical to Long Term Success of Biotech Firms
[ Fri, Oct 14th 2011 ] - Market Wire
Skanska Awarded R&D Lab Renovation Contract for USD 80 M, About SEK 512 M
[ Fri, Oct 14th 2011 ] - Market Wire
Columbia Laboratories to Present October 21st at NewsMakers in the Biotech Industry Conference
[ Fri, Oct 14th 2011 ] - Market Wire
Astex Pharmaceuticals to Present at NewsMakers in the Biotech Industry on October 21st
Thu, October 13, 2011
[ Thu, Oct 13th 2011 ] - Market Wire
Masimo to Report Third Quarter 2011 Financial Results After Market Close on October 25, 2011
[ Thu, Oct 13th 2011 ] - Market Wire
Allos Therapeutics Announces Settlement with Puta .. ntiffs Regarding Merger with AMAG Pharmaceuticals
[ Thu, Oct 13th 2011 ] - Market Wire
Amgen Appoints Robert A. Bradway to the Company's Board of Directors
[ Thu, Oct 13th 2011 ] - Market Wire
Masimo Launches the 2011 Radical-7 with rainbow® Acoustic Monitoring and In Vivo Adjustmenta"
[ Thu, Oct 13th 2011 ] - Market Wire
Cumberland Pharmaceuticals to Announce Third Quarter 2011 Financial Results on November 3, 2011
[ Thu, Oct 13th 2011 ] - Market Wire
Amgen Announces 2011 Fourth Quarter Dividend
[ Thu, Oct 13th 2011 ] - Market Wire
WuXi PharmaTech Acquires Abgent, a Leading Producer of Biological Research Reagents
[ Thu, Oct 13th 2011 ] - Market Wire
CML HealthCare Signs New Funding Agreement With t .. try of Health and Long Term Care for Lab Services
[ Thu, Oct 13th 2011 ] - Market Wire
Kindred Healthcare Commences Registered Exchange Offer for Its 8.25% Senior Notes Due 2019
[ Thu, Oct 13th 2011 ] - Market Wire
Incyte to Report Third Quarter 2011 Financial Res .. ide Update on Key Clinical Programs on October 27
[ Thu, Oct 13th 2011 ] - Market Wire
Hansen Medical to Exhibit Magellan(TM) Robotic Sy .. em at Vascular InterVentional Advances Conference

Anacor Pharmaceuticals to Present at the 10th Annual Bio Investor Forum


//health-fitness.news-articles.net/content/2011/ .. esent-at-the-10th-annual-bio-investor-forum.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


PALO ALTO, Calif.--([ BUSINESS WIRE ])--Anacor Pharmaceuticals (Nasdaq:ANAC) announced today that David Perry, the companya™s Chief Executive Officer, will provide a company overview at the 10th Annual Bio Investor Forum at 10:30 a.m. PT on Wednesday October 26, 2011 in San Francisco, California. The presentation will be webcast live and may be accessed under aEvents and Presentationsa on the Investors page of Anacora™s website at [ www.anacor.com ]. A replay will also be available for three months following the presentation.

About Anacor Pharmaceuticals

Anacor is a biopharmaceutical company focused on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. Anacor has discovered five compounds which are currently in clinical development, including its three lead programs: AN2690, a topical antifungal for the treatment of onychomycosis; AN2728, a topical anti-inflammatory PDE-4 inhibitor for the treatment of psoriasis and atopic dermatitis; and GSK 2251052, or GSK a052 (formerly referred to as AN3365), a systemic antibiotic for the treatment of infections caused by Gram-negative bacteria, which has been licensed to GlaxoSmithKline under the companies' research and development agreement. In addition, Anacor is developing AN2718 as a topical antifungal product candidate for the treatment of onychomycosis and skin fungal infections, and AN2898 as a topical anti-inflammatory product candidate for the treatment of psoriasis and atopic dermatitis. For more information visit [ http://www.anacor.com ].


Publication Contributing Sources